ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Shanghai Junshi Biosciences Co., Ltd. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 8.56% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -69.06
2
Flat results in Dec 23
- DEBT-EQUITY RATIO(HY) Highest at 0.00 times
- OPERATING PROFIT TO INTEREST (Q) Lowest at -88,478,554.00 times
- CASH AND CASH EQUIVALENTS(HY) Lowest at HKD 0.00 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 76.73%, its profits have risen by 38.4%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Junshi Biosciences Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Junshi Biosciences Co., Ltd.
76.73%
1.31
79.58%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.97%
EBIT Growth (5y)
8.56%
EBIT to Interest (avg)
-69.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.18
Tax Ratio
0.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.97
EV to EBIT
-5.13
EV to EBITDA
-6.99
EV to Capital Employed
0.97
EV to Sales
2.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-18.97%
ROE (Latest)
-18.53%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Shanghai Junshi Biosciences Co., Ltd.
Net Sales - Quarterly
At HKD 599 MM has Grown at 79.1 %
over average Net Sales of the previous four periods of HKD 334 MMMOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Operating Cash Flow - Annually
Highest at HKD 0.00 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales - Quarterly
Highest at HKD 599 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Inventory Turnover Ratio- Half Yearly
Highest at times
in the last five half yearly periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio- Half Yearly
Highest at times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Shanghai Junshi Biosciences Co., Ltd.
Operating Profit to Interest - Quarterly
Lowest at -88,478,554.00 times
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest (HKD MM)
Debt-Equity Ratio - Half Yearly
Highest at 0.00 times and Grown
each half year in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Profit Before Tax less Other Income (PBT) - Quarterly
At HKD -892 MM has Fallen at -25.5 %
over average PBT of the previous four periods of HKD -711 MMMOJO Watch
Near term PBT trend is negative
PBT less Other Income (HKD MM)
Cash and Cash Equivalents - Half Yearly
Lowest at HKD 0.00 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
